Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy

Policy A56857 is a billing and coding guidance article that complements Local Coverage Determination L36464 for HLA-DQB1*06:02 testing for narcolepsy but does not itself state specific coverage indications, limitations, documentation requirements, or frequency limits. For actionable criteria (medical necessity, exclusions, required documentation, frequency limits, and ICD-10 coding), consult LCD L36464.

"This billing/coding article references and defers to the Local Coverage Determination MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (LCD L36464) for medical necessity, coding, and documentation requ..."

Sign up to see full coverage criteria, indications, and limitations.